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Abstract
Pulse wave velocity (PWV), a measure of arterial stiffness, and intima-media thicken-
ing (IMT), a measure of early atherosclerosis, are intermediate markers of cardiovascular 
disease which are predictive of cardiovascular events. Traditionally, both were thought 
to result from accumulative exposure to traditional cardiovascular risk factors. However, 
their association with risk factors in young adults in low-income settings is unknown. 
We sought to investigate the association between PWV and IMT with traditional car-
diovascular risk factors in the Andhra Pradesh Children and Parents Study cohort from 
Southern India. Male and female adults (N = 1440) aged between 20 and 24 years un-
derwent measures of PWV and IMT. Exposure variables included smoking, body mass 
index (BMI), mean arterial pressure (MAP), glucose, homeostatic model assessment of in-
sulin resistance (HOMA-IR), total cholesterol, high-density lipoprotein cholesterol (HDL-
cholesterol), and triglycerides. Association between outcome and exposure variables 
was assessed using linear regression analysis. Average values for PWV and IMT were 
5.9 ± 0.6 m/s and 0.5 ± 0.1 mm. In univariable analysis, PWV associated with MAP, BMI, 
smoking, total cholesterol, glucose, and HOMA-IR and IMT associated with MAP, BMI, 
tobacco use, and HDL-cholesterol. In multivariable analysis, PWV remained strongly 
positively associated with MAP increasing by 0.5 m/s (P < .001) for a 10 mm Hg increase 
in MAP (R2 = .37). In contrast, IMT negatively associated with HDL-cholesterol (β = −.10; 
P = .012, R2 = .02). There was weak evidence that PWV and IMT positively associated 
with BMI. In young adults from Southern India, PWV positively associated with blood 
pressure and IMT negatively associated with HDL-cholesterol. This suggests separate 
etiologies for atherosclerosis and arterial stiffening in young adults.
1  | INTRODUC TION
Noncommunicable disease accounts for two-third of deaths world-
wide, of which 80% occur in low or middle-income countries.1 
Cardiovascular disease is a leading cause of morbidity and mortality 
from noncommunicable disease. Two main pathologies underlying 
cardiovascular disease are (a) development of atherosclerosis and (b) 
vascular remodeling which is often concomitant with atherosclerosis 
but can occur independently.2 While western countries have seen 
a recent reduction in age-adjusted cardiovascular mortality rates,1 
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mortality rates have continued to rise in low-income countries.3 In 
particular, India has some of the highest cardiovascular mortality 
rates in the world reaching an estimate of 349 deaths per 100 000 
in men and 265 per 100 000 in women.3 This rise in cardiovascular 
mortality is closely associated with demographic shifts, epidemio-
logical transition, and urbanization leading to changing behavior and 
dietary patterns.
Cardiovascular disease is a chronic disease which develops as 
a result of exposure to risk factors from childhood and throughout 
the life course.4 Structural and functional changes that occur in large 
arteries with age and from exposure to cardiovascular risk factors 
are important intermediate markers of subclinical cardiovascular dis-
ease. Of particular interest are measures of intima-media thickness 
(IMT) and pulse wave velocity (PWV). These measurements relate 
to development of atherosclerosis and vascular remodeling, respec-
tively. In addition, both PWV5 and IMT6 are predictors of cardiovas-
cular morbidity and mortality and strategies aimed at reducing their 
progression in early adulthood could reduce premature cardiovascu-
lar morbidity and mortality.
Traditionally, both IMT and PWV were thought to result from ac-
cumulative exposure to cardiovascular risk factors over the life course, 
explaining their association with cardiovascular morbidity and mortal-
ity.7 While an association between IMT and cardiovascular risk factors 
is well established,8 observational data suggest that PWV is primar-
ily influenced by increased blood pressure (BP) and diabetes9 but not 
other cardiovascular risk factors. However, these findings are based 
on data from high-income countries and across a wide range of age 
groups. A little is known about the association between IMT and PWV 
to traditional cardiovascular risk factors in low- and middle-income 
countries and at the early stages of vascular pathologies. To date, most 
of the studies looking at the association between PWV and traditional 
risk factors in young adults have been conducted in high-income 
countries.10-18 Two studies have been conducted in South Africa19 and 
Brazil20 but with a relatively small sample size of <220 participants. 
There are currently no studies looking at the association between both 
PWV and IMT to traditional risk factors in young individuals in low- or 
middle-income countries, including South-Asian communities.
The aim of the present study was to investigate the cross-sec-
tional association between PWV and IMT with traditional cardio-
vascular risk factors in male and female young adults aged between 
20 and 24 years in the Andhra Pradesh Children and Parents Study 
(APCAPS) cohort conducted in Southern India.
2  | METHODS
2.1 | Cohort profile
Andhra Pradesh Children and Parents Study is built upon the 
Hyderabad Nutrition Trial (HNT), Southern India, conducted be-
tween 1987 and 1990. APCAPS is a prospective cohort study which 
aimed to follow-up the children that took part in the HNT trial as pre-
viously described and is outlined in Figure 1.21 For the present study, 
data collected during the second wave between 2009 and 2010 was 
used in the analysis. The APCAPS study was approved by the Ethics 
Committee of the National Institute of Nutrition, Hyderabad, India, 
University of Bristol and the London School of Hygiene and Tropical 
Medicine, UK. Written informed consent was obtained from all sub-
jects. The present analysis was approved by the London School of 
Hygiene and Tropical Medicine Ethics Committee. The study pro-
tocol conforms to the ethical guidelines of the 1975 Declaration of 
Helsinki.
2.2 | Outcome variables
Pulse wave velocity was measured using the Vicorder device 
(Skidmore Medical Limited).21 Carotid and femoral artery pres-
sure waveforms were recorded simultaneously by placing BP cuffs 
around the neck (30 mm wide cuff) and upper thigh (100 mm wide 
cuff) with the subjects in the supine position (Figure 2). The cuffs 
were inflated to 60 mm Hg, and pressure waveforms were recorded 
for 3 seconds using a volume displacement method. The foot of the 
pressure waveform was identified using a cross-correlation algo-
rithm centered at the peak of the second derivative of pressure. 
The difference in time between pulse arrival at the carotid artery in 
comparison with the femoral artery was taken as the transit time. 
The difference in distance between the two sites was measured 
using a tape measure from the upper edge of the femoral cuff (dis-
tance 2, Figure 2) to the sternal notch minus the distance between 
the lower edge of the carotid cuff to the sternal notch (distance 
1, Figure 2). PWV was calculated by dividing the distance by the 
transit time in meters per second (m/s). PWV was measured three 
times, and the average was used for all further analysis.
For measurement of IMT, carotid artery was visualized using 
B-mode ultrasonography (Ethiroli Tiny-16a, Surabhi Biomedical 
Instrumentation India). IMT was measured as the distance between 
the first and second bright lines which represent the lumen-intima 
interface and media-adventitia interface, respectively. This technique 
has been shown to relate closely to measurements made using patho-
logical evaluations22 with a mean difference of 0.02-0.14 mm between 
repeat measures.23 IMT was measured offline using an image analysis 
package (Carotid Plaque Texture Analysis Software, Copyright LifeQ 
Ltd). Two measurements of IMT were made by separate operators and 
averaged, and the mean value of IMT was used for further analysis. 
Previous studies have reported good reproducibility of IMT measure-
ment using ultrasound with an intra- and inter-observer variability of 
5.4%-5.8% and 10.5%, respectively.24
2.3 | Exposure variables
2.3.1 | Blood pressure and heart rate
Blood pressure was measured three times, and an average was used 
for analysis. Measurements were made using an oscillometric device 
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Omron HEM 7300, which has been validated for accuracy according 
to the British Hypertension Society guidelines. MAP was calculated 
as [(2 × DBP) + systolic]/3. Heart rate (HR) was measured in trip-
licate using Omron M5-I (Omron, Matsusaka Co.), and an average 
of the three measurements was used for analysis. HR was normally 
distributed.
2.3.2 | Smoking
Information on whether a participant had smoked, chewed, or 
snuffed tobacco on a regular basis (at least weekly) was gathered as 
part of a questionnaire. Each participant was categorized according 
to the status of smoking, chewing, or snuffing tobacco as: current 
(used in the last 6 months), former (ceased use >6 months ago), or 
never smoked, chewed, or snuffed tobacco.
2.3.3 | Blood lipids
Total cholesterol was measured using an enzymatic cholesterol oxi-
dase method, HDLcholesterol was measured using an homogeneous 
assay, and triglycerides were measured using enzymatic colorimet-
ric, GPO-PAP method (Instrument: Synchron CX9, Reagent source: 
BeckmanCoulter). LDL-cholesterol was not used in analysis as it is 
derived from total cholesterol and HDL-cholesterol and would in-
troduce multicollinearity in the data analysis (observed correlation 
between LDL and total cholesterol was r = .94).
2.3.4 | Body mass index
For calculation of participant's BMI, weight (kg) measurements were 
made in duplicate using a digital weighing machine (Model PS16, Beurer). 
Height (mm) was also measured in duplicate with the participant stand-
ing using a portable Seca Leicester height measure, Chasmors. BMI 
was then calculated using the formula weight (kg)/height2 (m2), where 
weight and height were averages of the duplicate measures.
2.3.5 | Glucose and insulin
Glucose was measured by an enzymatic method using glucose oxi-
dase/peroxidase-4-aminophenazone-phenol method. Insulin was 
F I G U R E  1   Flow diagram of the number of participants adapted from Kinra et al21
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measured by an enzyme-linked immunosorbent assay method using 
solid phase, two-site enzyme immunoassay (Instrument: Rayto, 
Reagent source: Mercodia). Insulin resistance was calculated by 
multiplying measures of fasting insulin with fasting glucose to give 
the homeostatic model assessment of insulin resistance (HOMA-IR) 
which was used for further analysis.
2.3.6 | Alcohol consumption
Information on alcohol consumption was gathered as part of a ques-
tionnaire. Alcohol consumption was split according to intake of local 
spirits, branded spirits, wine, and beer and frequency of consump-
tion recorded. For each type of alcohol frequency of present con-
sumption was classified according to the following categories: daily/
most days, weekends only, 1-2 times a month, special occasions, and 
never. For further analysis, the alcohol type with the highest fre-
quency of drinking was used.
2.4 | Data analysis
Data analysis was performed using Stata version 14. A small 
number of individuals had a history of stroke (n = 1), coronary 
heart disease (n = 3) and taking medication for diabetes (n = 2), 
these participants were removed from further analysis giving a 
total sample size of 1440 participants (Table 1). For PWV, out of 
1440 participants, 1426 had measures of PWV. Of these 1400 
had PWV and no missing values for the other exposure variables 
and were included in the final multivariable model. For IMT, out 
of 1440 participants 1389 had measures of IMT. Of these, 1362 
had measures of IMT and no missing values for the exposure vari-
ables and were included in the final multivariable model. Subject 
characteristics are presented as mean and standard deviation for 
continuous variables and number and percentage for categori-
cal variables. Comparison between variables by sexand between 
those with complete and those with missing data was performed 
using Student's t test for continuous variables, chi-square test for 
binary variables and chi-square test for trend for ordered categori-
cal variables.
Univariable linear regression analysis was used to assess the 
association of PWV and IMT (outcome variables) to cardiovascular 
risk factor (exposure variable) adjusting for village clustering using 
robust standard errors using the cluster function within Stata, age, 
and sex. The number of individuals included in analysis, beta co-
efficient, 95% confidence interval, P-values (obtained using the 
Wald test), and coefficient of determination (R2) are presented in 
the results. Because the final multivariable model included only 
individuals without any missing data, univariable analysis was re-
peated only in individuals with complete data to ensure findings 
were consistent (Table S1 and S2). Linear regression assumes that 
residuals are normally distributed, and the validity of this assump-
tion was checked using a normal quantile plot. The assumption 
that there is constant variance among dependent and indepen-
dent variables was checked by plotting standardized residuals 
against the fitted values. In this analysis, it is assumed that the 
F I G U R E  2   Carotid cuff location 
around the neck and femoral artery cuff 
around the upper thigh and distance 
measurements adapted from Bailey et al43
     |  5CECELJA Et AL.
relationship between the outcome and exposure is linear. Linearity 
of an association was examined by adding quadratic terms to the 
model and significance examined using the Wald test. For easier 
interpretability of the beta coefficients, IMT was scaled up by a 
factor of ten and total cholesterol, triglyceride, serum glucose, 
HDL-cholesterol, and MAP were divided by 10.
For PWV, multivariable analysis model building initially in-
cluded MAP and measures of impaired glycemia as these were hy-
pothesized to be associated with PWV and were entered into the 
model first, adjusting for age, sex, and village cluster. Secondly, 
the model additionally tested for interactions between HR and 
MAP. The final model additionally included all other risk factors 
to investigate whether these were associated with PWV in this 
population. For IMT, model building initially included risk factors 
mainly associated with development of atherosclerosis including 
smoking, obesity, and dyslipidemia. Secondly, alcohol intake was 
included in the model and any confounding effect on smoking was 
examined. The final model additionally included all other risk fac-
tors to investigate whether these were associated with IMT. For 
easier interpretability, only variables with a P value <.10 and those 
hypothesized to be associated with the outcome variables are 
presented in the final model. Standard errors were examined for 
each new variable for evidence of collinearity. Standardized beta 
regression coefficient, 95% CI, P-values and R2 coefficient from 
the final model are presented in the results section. Linear regres-
sion assumptions for the final regression model were assessed as 
described for univariable analysis.
3  | RESULTS
3.1 | Participant characteristics
The mean age of all participants was 20.9 ± 1.6 years and 60% 
of participants were male (Table 1). Average values for IMT and 
PWV were 0.5 ± 0.1 mm and 5.9 ± 0.6 m/s, respectively, with 
weak evidence that PWV was slightly higher in men compared 
to women (mean PWV 5.9 vs 5.8 m/s, P = .09). Average BMI was 
19.5 ± 2.8 kg/m2. Most participants had never used tobacco (86%), 
13% were current smokers and 1% were former smokers with a 
higher prevalence of current male smokers compared to women 
(15% vs 10%). Forty-nine percent of participants had never had 
alcohol and most individual that did drink did so 1-2 times a month 
(19%) or on special occasions (16%). Fourteen percent drank on 
TA B L E  1   Characteristics of all participants and bysex
Characteristics (units, n = number of 
observations) Total cohort (N = 1440) Male (N = 858) Female (N = 575) P-value
Age (y, n = 1440) 20.9 ± 1.6 20.8 ± 1.1 20.9 ± 1.2 .017
BMI (kg/m2, n = 1439) 19.5 ± 2.8 19.5 ± 2.8 19.5 ± 3.0 .770
MAP (mm Hg, n = 1424) 84.0 ± 7.5 84.2 ± 7.5 83.7 ± 7.5 .297
Tobaccoa (n = 1438)
Never (n, [%]) 1239 [86.2] 715 [83.4] 519 [90.3] <.001b
Former (n, [%]) 12 [0.8] 11 [1.3] 1 [0.2]  
Current (n, [%]) 187 [13.0] 131 [15.3] 55 [9.6]  
Alcoholc (n = 1438)
Daily/most days (n, [%]) 30 [2.1] 22 [2.6] 8 [1.4] <.001b
Weekends only (n, [%]) 194 [13.5] 145 [16.9] 49 [8.5]  
1-2 times a month (n, [%]) 277 [19.3] 207 [24.2] 67 [11.6]  
Special occasions (n, [%]) 234 [16.3] 153 [17.9] 81 [14.1]  
Never (n, [%]) 703 [48.9] 330 [38.5] 370 [64.4]  
Total cholesterol (mg/dL, n = 1431) 154.1 ± 34.5 153.4 ± 33.6 155.2 ± 35.9 .330
HDL-cholesterol (mg/dL, n = 1431) 39.5 ± 7.6 38.8 ± 7.3 40.5 ± 7.8 <.001
Triglycerides (mg/dL, n = 1431) 101.7 ± 51.7 104.5 ± 57.0 97.5 ± 42.0 .012
Glucose (mg/dL, n = 1431) 86.4 ± 9.6 86.5 ± 9.6 86.3 ± 9.4 .687
Insulin (Uu/mL, n = 1431) 4.7 ± 3.7 4.6 ± 3.0 5.0 ± 4.4 .056
PWV (m/s, n = 1419) 5.9 ± 0.6 5.9 ± 0.6 5.8 ± 0.6 .091
IMT (mm, n = 1382) 0.54 ± 0.12 0.55 ± 0.16 0.54 ± 0.13 .145
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HR, heart rate; IMT, intima-media thickness; 
MAP, mean arterial blood pressure; PWV, pulse wave velocity; SBP, systolic blood pressure.
aSmoking or chewing tobacco, former user = ceased use >6 mo ago; current user = used in the last 6 mo. 
bChi- squared test for trend. 
cHighest frequency of local spirits, branded spirit, wine or beer. 
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weekends and only 2% drank on a daily basis. More men drank al-
cohol compared to women (61% vs 36%). Average values for total 
cholesterol, HDL-cholesterol and triglycerides were 154 ± 35, 
40 ± 8 and 102 ± 52 mg/dL, respectively. Average values for 
glucose and insulin were 86 ± 10 mg/dL and 4.7 ± 4 Uu/mL, re-
spectively. Men had higher triglycerides (105 vs 98 mg/dL), lower 
insulin (4.6 vs 5.0 Uu/mL), and lower HR (73 vs 80 bpm) when com-
pared to women.
3.2 | Univariable analysis
After adjusting for age, sex, and village clusters, there was strong 
evidence of a positive linear association between PWV and MAP, 
BMI, total serum cholesterol, triglycerides, glucose, and HOMA-IR 
(Table 2). There was no association with HDL-cholesterol. There was 
strong evidence of a negative association between PWV and fre-
quency of drinking and weak evidence of an association with smok-
ing status (P = .057).
There was evidence of a positive association between IMT and 
tobacco use (P = .017), frequency of drinking (P = .03), BMI (P = .065) 
and a negative association with HDL-cholesterol. There was no ev-
idence of an association between IMT and MAP, total cholesterol, 
triglyceride, and glucose.
3.3 | Multivariable analysis
The first model included PWV as the outcome variable and MAP, 
glucose and HOMA-IR as explanatory variables, adjusting for age, 
sex, and village clusters only. MAP remained strongly associated with 
PWV, similarly to univariable analysis PWV increased by 0.5 m/s (95% 
CI: 0.43, 0.51; P < .001, Table 3) for an 10 mm Hg increase in MAP. 
There was no evidence of an association between PWV and glucose 
or HOMA-IR. The second model additionally included an interaction 
term between HR and MAP. There was no evidence of an association 
between PWV and HR or evidence that HR modified the associa-
tion between PWV and MAP. The final model additionally adjusted 
for all other cardiovascular risk factors. The results remained similar 
for the association between PWV and MAP, glucose, and HOMA-IR 
and the size of the association between PWV and MAP was very 
slightly affected with the beta coefficient moving a little toward 
zero showing minimal confounding by other risk factors. There was 
evidence of an independent positive association between PWV and 
BMI. Inclusion of BMI increased the percentage variance explained 
by the multivariable model from 37% to 38%. Recalculated MAP 
using only the last 2 blood pressure measurements as recommended 
by the European guidelines for hypertension25 did not change the 
strength of the association with pulse wave velocity. There was no 
evidence of an independent association between PWV with HR, 
total cholesterol, HDL-cholesterol, triglycerides, smoking or alcohol. 
The results remained unchanged in sensitivity analysis that excluded 
outliers (Table S3).
The first model included IMT as the outcome variable and total 
cholesterol, HDL-cholesterol, BMI, triglycerides and smoking as 
explanatory variables, adjusting for age, sex, and village clusters 
only. Within this model, IMT remained negatively associated with 
HDL-cholesterol (β = −.10; 95% CI: −0.01, −0.01, P = .013, Table 4). 
The beta coefficient was the same as that reported in univariable 
analysis suggesting that addition of other risk factors did not con-
found the association between IMT and HDL-cholesterol. There was 
weak evidence of an independent positive association between IMT 
and BMI where IMT increased by 0.002 mm (95% CI: 0.00, 0.005; 
P = .098) for a one unit increase in BMI (Table 4). The beta coeffi-
cient was the same as observed in univariable analysis making con-
founding unlikely. There was no evidence that IMT was associated 
with total cholesterol, tobacco use or triglyceride levels within the 
model. The second model additional included alcohol use. There 
was no evidence of an association between alcohol and IMT but the 
non-significant beta coefficients between smoking and IMT was re-
duced. The final multivariable model included all cardiovascular risk 
factors. Evidence of an independent negative association between 
IMT and HDL-cholesterol and BMI remained unchanged. However, 
the final model accounted for only 2% of the variance in IMT. There 
was no evidence of an association between IMT and smoking, alco-
hol, BMI, glucose, HOMA-IR, MAP, triglycerides or total cholesterol. 
Recalculated MAP using only the last 2 blood pressure measure-
ments did not change the association with intima-media thickness. 
The results remained unchanged in sensitivity analysis that excluded 
outliers and when analysis was limited to participants with IMT 
under 0.90 mm (Table S4 and S5, respectively).
4  | DISCUSSION
The present study investigated the association between PWV and 
IMT to cardiovascular risk factors in young adults from a transition-
ing rural community in Southern India taking part in the APCAPS 
study. The first major finding is that PWV strongly positively associ-
ated with MAP, accounting for 37% of the variability in PWV, but not 
to other traditional cardiovascular risk factors. There was a modest 
positive association between PWV and BMI but not with other risk 
factors including serum cholesterol levels, lipoproteins, triglycerides, 
tobacco use or impaired glycemia. The second key finding in the pre-
sent study is that there was a strong negative association between 
IMT and HDL-cholesterol, accounting for 2% of the variability in IMT, 
but not with other modifiable cardiovascular risk factors.
The average PWV in the present cohort was 5.9 ± 0.6 m/s 
which is comparable to that observed previously for the same 
age group in studies conducted in high-income countries.10-18 Our 
findings of an association between PWV and BP are also consis-
tent with previous studies in young adults in high-income coun-
tries10-18 and in one study conducted in Brazil.20 This suggests 
that the process of arterial stiffening in young individuals may 
be comparable between low- and high-income countries. High 
BP may directly increase arterial stiffness by transferring stress 
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from more compliant elastin fibers to stiffer collagen fibers at 
higher pressure.26 Alternatively and/or concomitantly, increased 
large artery stiffness can causally increase BP, through reduced 
buffering of the pulse pressure increase following left ventricu-
lar contraction.27 Due to the cross-sectional nature of the pres-
ent study, the direction of the relationship between PWV and BP 
could not be ascertained. However, a recent longitudinal study 
conducted in over 4000 Chinese adults showed elevated PWV to 
precede development of isolated systolic hypertension after ad-
justment for baseline BP.28 The present study also found a modest 
positive association between PWV and BMI. This association has 
been previously observed in cross-sectional11-14 and longitudinal 
studies.29 However, PWV measurements may be biased when dis-
tance measurements are measured over body surface area as any 
abdominal obesity may overestimate the distance or vice versa. 
In support of this, a recent study found a positive association be-
tween BMI when distance was measured using surface measure-
ment. However, this association disappeared once aortic distance 
was measured using magnetic resonance imaging (MRI).30
Lack of association between PWV and measures of impaired 
glycemia in multivariable analysis is surprising as previous studies 
in adults have reported an association between PWV and diabetes.9 
However, in these studies the reported association was relatively 
weak and accounted for 5% of the variability in PWV which may 
not be detectable in this young cohort of healthy individuals with 
low levels of glucose.9 In support of this, cross-sectional analysis of 
young adults with type I diabetes or those classified as pre-diabetic 
did not have elevated PWV compared to healthy individuals.13,14 The 
lack of association between PWV and other traditional cardiovas-
cular risk factors including smoking and measures of dyslipidemia 
is consistent with findings from cross-sectional9 and longitudinal 
studies31 conducted in adults. Taken together this suggests that the 
process of arterial stiffening is separate from the pathological pro-
cess of atherosclerosis and is consistent with a lack of correlation 
between measures of atherosclerosis and stiffening measured along 
the same vascular region.32,33
The second key finding in the present study is that there was 
a strong negative association between IMT and HDL-cholesterol, 
although this accounted for a small proportion of the variability in 
IMT (2%). This is consistent with some studies from high-income 
countries in young adults,34,35 but not all.17,36,37 A meta-analy-
sis that included >21 000 adults reported a negative association 
between HDL-cholesterol and IMT, after adjustment for other 
atherosclerosis risk factors.38 Furthermore this association was 
TA B L E  2   Univariate linear regression analysis of the association of PWV and IMT (per 10 mm) to cardiovascular risk factors adjusted for 
age, sex, and village level clustering (analysis is limited to participants with complete data with each line representing separate models)
Variable
Pulse wave velocity Intima-media thickness
β 95% CI P-value β 95% CI P-value
MAP (per 10 mm Hg) .48 0.43, 0.52 <.001 .04 −0.07, 0.16 .453
BMI (kg/m2) .06 0.04, 0.07 <.001 .02 0.00, 0.04 .065
Tobacco categoriesa
Never Reference  .057b Reference  .017b
Former .25 −0.18, 0.69 −.29 −0.07, 0.18
Current .14 −0.02, 0.29 .25 0.02, 0.49
Alcohol categoryc
Daily/most days Reference  <.001b Reference  .032b
Weekends only .17 −0.06, 0.40 −.12 −0.69, 0.44
1-2 times a month .15 −0.09, 0.37 −.24 −0.97, 0.49
Special occasions .16 −0.09, 0.41 −.21 −0.97, 0.55
Never .03 −0.19, 0.25 −.39 −1.15, 0.38
Total cholesterol (per 10 mg/dL)) .03 0.01, 0.04 <.001 .00 −0.02, 0.01 .529
HDL-cholesterol (per 10 mg/dL) .02 −0.03, 0.08 .335 −.10 −0.18, −0.03 .007
Triglycerides (mg/dL) .24 0.13, 0.35 <.001 −.01 −0.13, 0.11 .828
Glucose (per 10 mg/dL) .06 0.03, 0.09 <.001 −.05 −0.12, 0.03 .207
HOMA-IR .17 0.11, 0.23 <.001 −.08 −0.19, 0.02 .116
Note: Analysis was adjusted for age, sex, and village clustering.
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance; HR, heart rate; 
MAP, mean arterial blood pressure; PWV, pulse wave velocity.
aSmoking or chewing tobacco, former user = ceased use >6 mo ago; current user = used in the last 6 mo. 
bP-value for all categories. 
cThe highest frequency for either local spirits, branded spirit, wine or beer. 
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maintained even at low LDL-cholesterol suggesting a protective 
mechanism which is independent from LDL-cholesterol and total 
cholesterol.38 This is consistent with the findings of the present 
study where we found no association between IMT and total cho-
lesterol. Together these findings suggest a protective role of HDL-
cholesterol in IMT progression in young adults in both high- and 
low-income countries. The mechanism by which HDL-cholesterol 
may have protective effects on IMT progression is incompletely 
understood but is likely to involve protecting the blood ves-
sel wall from initiation of fatty streaks by removing cholesterol 
from macrophages, preventing foam cell formation and reducing 
inflammation.39
A lack of association between triglyceride and IMT observed in 
the present study is consistent with the findings from previous stud-
ies in the same age group from high-income countries.17,34,35,37,40 In 
addition, the present study found no association between IMT and 
either BMI or tobacco use. In the present study, the range of BMI 
was 16.7-22.9. Previous studies from high-income countries where 
BMI was associated with IMT had larger BMI range with a mean of 
26.8 in the Muscatine offspring study,36 24.7 in the ARYA study17 
and 28.0 In the Bogalusa Heart study.35 This suggests the absence of 
an association between BMI and IMT may be explained by a lack of 
exposure to obesity in this cohort. Consistent with previous studies, 
tobacco use did not associate with IMT in the present study. A lack of 
association between IMT and smoking may be due to the relatively 
recent onset of smoking.36
There was no association between IMT with BP and impaired gly-
cemia. High IMT may results from development of fatty streaks within 
the intima of the blood vessel wall as part of the atherosclerotic pro-
cess. In addition, vascular smooth cell hypertrophy within the media 
may also explain increased intima-media thickness. Smooth muscle 
cell hypertrophy is primarily caused by elevated BP41 and could explain 
the observed association between IMT and BP which has previously 
been reported.17,34,36,37 In the present study, a lack of association be-
tween IMT and BP suggests that variation in IMT may primarily be due 
to intimal changes as part of the atherosclerotic process rather than 
vascular remodeling due to raised BP. The present study found no as-
sociation between measures of impaired glycemia and IMT. It is well 
established that individuals with diabetes have a higher risk of cardio-
vascular events compared to non-diabetic individuals. However, the 
association between measures of impaired glycemia in non-diabetic 
patients to cardiovascular events is inconsistent42 and in line with the 
findings of the present study.
4.1 | Strengths and limitations
The present study has several methodological strengths which 
should be noted. Firstly, to the best of our knowledge this is the first 
study to investigating the association between PWV and IMT to tra-
ditional cardiovascular risk factors in a cohort of young individuals 
from a transitioning rural community in Southern India which are 
high-risk areas for cardiovascular disease. Secondly, the outcome 
variables were measured using gold-standard techniques for assess-
ing aortic stiffness and carotid atherosclerosis which are important 
intermediate measures of vascular disease that are predictive of fu-
ture cardiovascular disease.
There are also several limitations to the present study which 
should be noted. The cross-sectional nature of the present study 
does not allow determination of the direction of association. 
However, current understanding makes it highly unlikely that PWV 
or IMT may lead to changes in traditional risk factors. PWV and 
IMT were measured in triplicate with operator blinded to exposure 
variables (other than BMI) reducing the impact of observer bias. In 
addition, IMT measurement was confined to the carotid artery and 
may not represent the extent of atherosclerosis in other vascular 
beds. This non-differential misclassification could bias the results 
toward the null. Additionally, exposure variables were measured 
only at one time point and may not represent accumulative ex-
posure, if this single measurement underestimated accumulative 
exposure this would reduce the magnitude of the estimated effect 
for that exposure and vice versa. From the data available, it is not 
clear in what direction the bias would occur. We did not measure 
alcohol consumption in units per week which would be a more ac-
curate measure. However, we feel that this is unlikely to impact 
our main conclusions as alcohol consumption was low with most 
TA B L E  3   Final multivariate regression model of the association 
between PWV (m/s) and cardiovascular risk factors
 β
95% 
Confidence 
interval P-value R2
Model 1 (adjusted for age,sex, and village clusters)
MAP (per 
10 mm Hg)
.47 0.43, 0.51 .001 .37
Glucose (per 10 mg/
dL)
.01 −0.02, 0.05 .385
HOMA-IR .00 −0.04, 0.05 .840
Model 2 (adjusted for age, sex, and village clusters, interaction term 
between HR and MAP)
MAP (per 
10 mm Hg)
.42 0.26, 0.58 <.001 .37
Glucose (per 10 mg/
dL)
.01 −0.02, 0.05 .387
HOMA-IR −.01 −0.02, 0.01 .878
Model 3 (adjusted for age, sex, village clusters, total cholesterol, 
HDL-cholesterol, triglycerides, smoking, and alcohol)
MAP (per 
10 mm Hg)
.45 0.41, 0.49 <.001 .38
Glucose (per 10 mg/
dL)
.02 −0.02, 0.05 .344
HOMA-IR −.01 −0.06, 0.04 .683
BMI (kg/m2) .01 −0.01, 0.02 .044
Abbreviations: BMI, body mass index; HOMA-IR, homeostatic model 
assessment of insulin resistance; MAP, mean arterial pressure; β, beta 
coefficient.
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individuals (85%) drinking only 1-2 times a month (of these 49% 
were completely abstinent).
5  | CONCLUSION
In the present cross-sectional study including male and female 
young adults from Southern India we found strong evidence of 
an (a) positive association between PWV and BP which accounted 
for 37% of the variability in PWV and (b) negative association 
between IMT and HDL-cholesterol which accounted for 2% of the 
variability in IMT.
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